Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam in elderly patients undergoing thoracic surgery
ChiCTR2100052311Phase 4Not yet recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Oct 2021
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, propofol and flumazenil in None (3 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoint: Success rate of anesthesia and sedation. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
remimazolampropofolflumazenil
Beyond the preview
Go deeper on ChiCTR2100052311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052311.